XML 25 R11.htm IDEA: XBRL DOCUMENT v3.8.0.1
Cash Equivalents & Marketable Securities
12 Months Ended
Dec. 31, 2017
Cash Equivalents & Marketable Securities  
Cash Equivalents & Marketable Securities

3. Cash Equivalents & Marketable Securities

 

Cash equivalents and marketable securities consisted of the following at December 31, 2017 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross

 

Gross

 

 

 

 

Amortized

 

Unrealized

 

Unrealized

 

Fair

December 31, 2017

    

Cost

    

Gains

    

Losses

    

Value

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

134,635

 

$

 —

 

$

 —

 

$

134,635

U.S. Treasuries

 

 

11,995

 

 

 —

 

 

 —

 

 

11,995

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasuries

 

 

123,606

 

 

 —

 

 

(47)

 

 

123,559

Government agency securities

 

 

58,979

 

 

 —

 

 

(29)

 

 

58,950

Total cash equivalents and marketable securities

 

$

329,215

 

$

 —

 

$

(76)

 

$

329,139

 

Cash equivalents and marketable securities consisted of the following at December 31, 2016 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross

 

Gross

 

 

 

 

Amortized

 

Unrealized

 

Unrealized

 

Fair

December 31, 2016

    

Cost

    

Gains

    

Losses

    

Value

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

185,323

 

$

 —

 

$

 —

 

$

185,323

Total cash equivalents and marketable securities

 

$

185,323

 

$

 —

 

$

 —

 

$

185,323

 

At December 31, 2017, the Company held 25 securities that were in an unrealized loss position. The aggregate fair value of securities held by the Company in an unrealized loss position for less than 12 months at December 31, 2017 was $174.0 million, and there were no securities held by the Company in an unrealized loss position for more than 12 months. As of December 31, 2017, the Company did not intend to sell, and would not be more likely than not required to sell, the securities in an unrealized loss position before recovery of their amortized cost bases. Furthermore, the Company has determined that there was no material change in the credit risk of these securities. As a result, the Company determined it did not hold any securities with any other-than-temporary impairment as of December 31, 2017.

 

There were no realized gains or losses on available-for-sale securities during the year ended December 31, 2017 and 2016.